All In Biotech

Drug Trial Radar · NCT06481189

A Safety, Pharmacokinetics and Pharmacodynamics Study of GNR-086 and Ilaris® in Healthy Volunteers

A Single-blind Randomized Parallel-group Comparative Study of the Pharmacokinetics, Pharmacodynamics, Safety and Immunogenicity of GNR-086 and Ilaris® After a Single Subcutaneous Administration to Healthy Volunteers at a Dose of 150 mg

Last checked: Nov 19, 2026Latest source record: Jul 1, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 105 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

105

Actual

Start

Sep 6, 2022

Primary completion

Mar 17, 2023

Study completion May 26, 2023

Sponsor

Lead sponsor
AO GENERIUMIndustry
Sponsor type
Industry
First posted
Jul 1, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Other
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 45 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This is a randomized single-blind comparative parallel group study of the safety, pharmacokinetics and pharmacodynamics of GNR-086 and Ilaris® in healthy volunteers. Participants received a single subcutaneous dose of canakinumab 150 mg. The follow up period was 120 days.

Conditions

  • Healthy Volunteers

Interventions

  • GNR-086Biological

    The test drug GNR-086 was administered as a subcutaneous injection at a single dose of 150 mg.

  • Ilaris®Biological

    The reference drug Ilaris® was administered as a subcutaneous injection at a single dose of 150 mg.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Pharmacokinetics: Area under the plasma concentration versus time curve (AUC)Time frame: Day 120
  2. Pharmacokinetics: Peak Plasma Concentration (Cmax)Time frame: Day 120

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • State budgetary healthcare institution of the city of Moscow "City Clinic No. 2 of the Moscow Health Department"

    Moscow, Russia

  • Federal State Budgetary Educational Institution of Higher Education "Moscow State Medical and Dental University named after A.I. Evdokimov" of the Ministry of Health of the Russian Federation

    Moscow, Russia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.